Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: A real-world observational study in the United States Research Letter

   

Authors:	Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O’Byrne, L.; Happ, L. P.; Germain, G.; Urosevic, A.; Mahendran, M.; Duh, M. S.; Laliberté, F.; Cavo, M.; Lee, H. C.
Title:	Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: A real-world observational study in the United States
Keywords:	adult; monotherapy; united states; multiple myeloma; observational study; human; male; female; article; belantamab mafodotin
Journal Title:	Haematologica
Volume:	110
Issue:	3
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2025-03-01
Start Page:	753
End Page:	757
Language:	English
DOI:	10.3324/haematol.2024.285893
PUBMED:	39415693
PROVIDER:	scopus
PMCID:	PMC11877074
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-86000311820&doi=10.3324%2fhaematol.2024.285893&partnerID=40&md5=0e702a243cb4ee3eae4b8bdfffdf980b
Notes:	Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Malin Hultcrantz -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/223760